Consensus Cardlytics, Inc.

Equities

CDLX

US14161W1053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
11.58 ^USD	+0.56%		-2.97%	+25.79%

Apr. 25	Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing	MT
Apr. 09	Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors	CI

Evolution of the average Target Price on Cardlytics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

78af8d44ec5a23b5783cc6d8efb9c0c1.X79Ca91oWTMUND2y7cZaIJdz1IVpGPZZDsSXPsrqvEs.PdovGowuOHlfYXrKo5cDEt8bhLMrLbE0S7HnefyhigQl4HATtC8vcCRRfA~12e8b9cae0a77a09fcc9ff1bcc6dea03

Analyst Recommendations on Cardlytics, Inc.

Cardlytics Insider Sold Shares Worth $278,885, According to a Recent SEC Filing	Apr. 25	MT
Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating	Apr. 09	MT
Cardlytics Insider Sold Shares Worth $448,020, According to a Recent SEC Filing	Apr. 03	MT
Craig-Hallum Upgrades Cardlytics to Buy From Hold, Adjusts Price Target to $18 From $10	Mar. 15	MT
Lake Street Adjusts Cardlytics' Price Target to $18 From $13, Maintains Buy Rating	Mar. 15	MT
Lake Street Starts Coverage on Cardlytics with Buy Rating, $13 Price Target	Nov. 29	MT
Needham Adjusts Price Target on Cardlytics to $19 From $10, Maintains Buy Rating	23-08-02	MT
Needham Adjusts Price Target on Cardlytics to $10 From $8, Maintains Buy Rating	23-05-05	MT
Wells Fargo Adjusts Price Target on Cardlytics to $6 From $5, Keeps Underweight Rating	23-04-12	MT
JPMorgan Adjusts Cardlytics Price Target to $6 From $7, Maintains Neutral Rating	23-03-02	MT
Wells Fargo Adjusts Price Target on Cardlytics to $5 From $6, Keeps Underweight Rating	23-03-02	MT
Needham Lowers Price Target on Cardlytics to $8 From $14, Maintains Buy Rating	23-03-02	MT
Wells Fargo Adjusts Price Target on Cardlytics to $6 From $10, Maintains Underweight Rating	23-01-09	MT
Needham Adjusts Price Target on Cardlytics to $14 From $19, Maintains Buy Rating	22-11-02	MT
Wells Fargo Adjusts Cardlytics Price Target to $10 From $13, Maintains Underweight Rating	22-11-02	MT
Wells Fargo Downgrades Cardlytics to Underweight From Equalweight, Trims Price Target to $13 From $14	22-09-08	MT
Wells Fargo Trims Cardlytics Price Target to $14 From $15, Maintains Equalweight Rating	22-08-03	MT
Needham Adjusts Cardlytics' Price Target to $19 From $24, Reiterates Buy Rating	22-08-03	MT
Wells Fargo Downgrades Cardlytics to Equalweight From Overweight, Adjusts Price Target to $15 From $72	22-07-14	MT
Needham Adjusts Cardlytics' Price Target to $24 from $60, Keeps Buy Rating	22-07-13	MT
BofA Securities Downgrades Cardlytics to Underperform From Neutral, Adjusts PT to $14 From $56, Shares Down 2% Premarket	22-07-13	MT
Craig-Hallum Downgrades Cardlytics to Hold from Buy, Lowers Price Target to $20 from $50	22-07-12	MT
JPMorgan Adjusts Price Target on Cardlytics to $35 From $47, Maintains Neutral Rating	22-06-29	MT
Craig-Hallum Adjusts Cardlytics' Price Target to $50 from $70, Keeps Buy Rating	22-05-03	MT
Needham Adjusts Cardlytics' Price Target to $60 From $85, Keeps Buy Rating	22-05-03	MT